Impact of the US Food and Drug Administration’s safety-related announcements on the use of bisphosphonates after hip fracture

The U.S. FDA issued several announcements related to potential risk of bisphosphonates including osteonecrosis of the jaw (2005), atrial fibrillation (2007) and atypical femur fracture (2010). We aimed to evaluate the impact of three FDA drug safety announcements on the use of bisphosphonates in pat...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Bone Miner Res
Hoofdauteurs: Kim, Seoyoung C., Kim, Dae Hyun, Mogun, Helen, Eddings, Wesley, Polinski, Jennifer M., Franklin, Jessica M., Solomon, Daniel H
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2016
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5040596/
https://ncbi.nlm.nih.gov/pubmed/26969902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.2832
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items